GOOD NEWS ONLY.← All news
Economy · Weltweit · Original source dated 2026-10-30 ·

AstraZeneca's profit rises 23% on cancer drugs and unveils cost-saving plan

AstraZeneca reported a 23% net profit increase in Q3 on strong cancer drug sales, alongside a $1.5 billion savings program.

In its third-quarter report, AstraZeneca announced a 23% increase in net profit year-over-year, largely driven by booming sales of its cancer drugs. The British pharmaceutical firm also revealed a significant cost-saving plan aimed at saving $1.5 billion annually to reinvest in the development of new medicines. This initiative is expected to improve resource allocation and expedite product development.

Sources and context

Source: Euronews Welt

Original source ↗